Shares Homepage - BSE Sensex, NSE Nifty, Latest Prices, Live News, Company Search, Result Annoucements, Company News, Top stories, Gainers Losers, Top Performers, Market Commentary, Live Quotes, Bulk Deals
India's preferred Personal finance destination
Home Shares News Centre F&O Mutual Funds IPO Portfolio Commodity Loans Financial Planning Insurance About Us
Markets Companies Research Industries E-Mail Page
Wealth Tracker    Newsletter   Tax Corner NRI Centre Forums E-Mail Chat Masala Feedback
my Last 5 Scrips
Company BSE Price(Rs) % Chg
Ntpc Ltd 150.25 1.08
Tata Stl 313.15 4.56
State Ba 2151.15 1.15
Tata Mot 288.10 0.93
Hindalco 107.10 1.70
Clear All Clear Last
Shares
NSE Live
Nifty Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
BSE Live
BSE30 Live Prices
Live Quotes
Top Gainers/Losers
Top 10 Turnover
No Delivery Stocks
Market Pulse
Leaders
Laggards
FII Activity
Mutual Fund Activity
Meetings
Results Watch
Results Calendar
Results Announced
IPO Watch
Company
Snapshots
Quotes
Charts
Financials
Recent News
Broker Research
Meetings
Research Tutorial
Discussion Forum
Research
Research Reports
Sector Watch
Economy Watch
Snapshot-Novartis India Limited
Novartis India Limited
Sector:Pharmaceuticals Pharmaceuticals - Formulations
BSE:500672NSE:NOVARTINDBloomberg:HCBA@INReuters:NOIN.BO
Market Lot: 1Face Value: 5ISIN Demat: INE234A01025
QuotesSnapshotChartsFinancialsResearchRecent News
Peer GroupAGM/AMMF HoldingDiscussion ForumBSE/NSE NoticesBSE/NSE Deals

 
 
Recent Developments
26-OCT-12 Novartis India, a world leader in the research and development of products to protect and improve health and well-being. reported a fall of 8.89% in net profit to Rs 393.4 million for the quarter ended Sept 30, 2012 as compared to Rs 431.8 million in the same period last year 14-JUN-11 With reference to the news item appearing in a financial daily titled `Novartis surges 12% on the BSE amid delisting buzz`, Novartis India has clarifi...   More..
Business Profile Future Plans
One To One
Recent news
Latest News
Novartis AG appoints Citigroup as sole broker for share sale in Indian entity  -IRIS 09-May-13
Previous

More


Brief Financials (in Rs. Mn.)Detailed Quarterly
Period ending (months)31-Mar-2012 (12)31-Mar-2011 (12)31-Mar-2010 (12)
Net sales 8442.807086.406241.00
Other Income840.10631.90438.30
Total Income9282.907718.306679.30
Cost of goods sold7004.005876.605196.90
OPBDIT2278.901841.701482.40
PAT1520.201466.701159.90
Gross Block---
Equity capital159.80159.80159.80
EPS (Rs.)47.5645.9036.29
DPS (Rs.)---
BV (Rs.)---
P/E range (x)12.96 - 19.8511.87 - 16.019.92 - 16.53
Debt / Equity (x)---
Operating margin (% of OI)24.523.922.2
Net margin (% of OI)16.419.017.4
Detailed Financials
Income 
Statement
Balance Sheet Latest 
Quarterly/Halfyearly
Ratio Analysis Share Statistics
Price Charts
Scrip Information



Registered Office
ADDRESS
Sandoz House
Shivsagar Estate
Dr. Annie Besant Road
Worli
Mumbai
Maharashtra-400 018
PHONE
(022) 2495 8675/ 8400
FAX
(022) 2493 8666
 
Board of Directors
NSE/BSE Announcements


Home | Shares | F&O | Mutual Funds | Loans | Insurance | News Centre
Trade On-line | Wealth Tracker | Newsletters | Tax Corner | NRI Centre | Forums | E-mail | Chat | Search in myiris | Advertise
© All rights reserved. IRIS Business Services Limited
Disclaimer